Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma

Leukemia Research

Volumn 35, Issue 3, 2011, Pages 334-339

  Beltran, Brady ^a   Quiñones, Pilar ^a   Morales, Domingo ^a   Cotrina, Esther ^a   Castillo, Jorge J ^b  

^a HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^b BROWN UNIVERSITY   (United States)

Author keywords

Adult T cell leukemia lymphoma; ATLL; IPI score; PIT score; Prognostic factors

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CALCIUM; LACTATE DEHYDROGENASE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BONE MARROW METASTASIS; CALCIUM BLOOD LEVEL; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SPLEEN DISEASE; SYMPTOM; T CELL LEUKEMIA;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; BETA 2-MICROGLOBULIN; CALCIUM; FEMALE; FLOW CYTOMETRY; HUMANS; L-LACTATE DEHYDROGENASE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79952106394     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.08.006     Document Type: Article

References (31)

1. Ohshima K., Jaffee E., Kikuchi M. Adult T-cell leukaemia/lymphoma. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, International Agency for Research on Cancer (IARC), Lyon, France. S. Swerdlow (Ed.).
2. Bittencourt A.L., Barbosa H.S., Vieira M.D., et al. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases. Acta Oncol 2009, 48(4):598-604.
3. Ferreira O.C., Planelles V., Rosenblatt J.D. Human T-cell leukemia viruses: epidemiology, biology, and pathogenesis. Blood Rev 1997, 11(2):91-104.
4. Alarcon J.O., Friedman H.B., Montano S.M., et al. High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in Peru. J Acquir Immune Defic Syndr 2006, 42(5):604-609.
5. Sanchez-Palacios C., Gotuzzo E., Vandamme A.M., et al. Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women. Int J Infect Dis 2003, 7(2):132-137.
6. Bittencourt A.L., da Gracas Vieira M., Brites C.R., et al. Adult T-cell leukemia/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients. Am J Clin Pathol 2007, 128(5):875-882.
7. Inagaki A., Ishida T., Ishii T., et al. Clinical significance of serum Th1-Th2- and regulatory T-cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors. Int J Cancer 2006, 118(12):3054-3061.
8. Ishida T., Utsunomiya A., Iida S., et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003, 9(10 Pt 1):3625-3634.
9. Ohno N., Tani A., Uozumi K., et al. Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemia. Blood 2001, 98(4):1160-1165.
10. Sadamori N. Clinical and biological significance of serum tumor markers in adult T-cell leukemia. Leuk Lymphoma 1996, 22(5-6):415-419.
11. Shimamoto Y., Ono K., Sano M., et al. Differences in prognostic factors between leukemia and lymphoma type of adult T-cell leukemia. Cancer 1989, 63(2):289-294.
12. Shimoyama M., Ota K., Kikuchi M., et al. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. J Clin Oncol 1988, 6(7):1088-1097.
13. Suzumiya J., Ohshima K., Tamura K., et al. The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. Ann Oncol 2009, 20(4):715-721.
14. Takasaki Y., Iwanaga M., Tsukasaki K., et al. Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL). Leuk Res 2007, 31(6):751-757.
15. Tawara M., Hogerzeil S.J., Yamada Y., et al. Impact of p53 aberration on the progression of adult T-cell leukemia/lymphoma. Cancer Lett 2006, 234(2):249-255.
16. Tsukasaki K., Hermine O., Bazarbachi A., et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia/lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009, 27(3):453-459.
17. Utsunomiya A., Ishida T., Inagaki A., et al. Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: a blood eosinophilia is a significant unfavorable prognostic factor. Leuk Res 2007, 31(7):915-920.
18. Yamada Y., Hatta Y., Murata K., et al. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 1997, 15(5):1778-1785.
19. Major prognostic factors of patients with adult T-cell leukemia/lymphoma: a cooperative study. Lymphoma Study Group (1984-1987). Leuk Res 1991, 15(2-3):81-90.
20. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-1987). Br J Haematol 1991, 79(3):428-437.
21. A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993, 329(14):987-994.
22. Gallamini A., Stelitano C., Calvi R., et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004, 103(7):2474-2479.
23. Poiesz B.J., Ruscetti F.W., Gazdar A.F., et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77(12):7415-7419.
24. Uchiyama T., Yodoi J., Sagawa K., et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977, 50(3):481-492.
25. Yoshida M., Miyoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982, 79(6):2031-2035.
26. Yamada Y., Soda M., Iwanaga M., et al. A nation-wide survey of HTLV-1-associated adult T-cell leukemia/lymphoma (ATLL) in Japan 2010, European Hematology Association, Barcelona, Spain, [abstract 0302].
27. Oshiro A., Tagawa H., Ohshima K., et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood 2006, 107(11):4500-4507.
28. Yamada Y., Kamihira S., Murata K., et al. Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin's lymphoma. Leuk Lymphoma 1997, 26(3-4):327-335.
29. Tsukasaki K., Utsunomiya A., Fukuda H., et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia/lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007, 25(34):5458-5464.
30. Fukushima T., Miyazaki Y., Honda S., et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 2005, 19(5):829-834.
31. Utsunomiya A., Miyazaki Y., Takatsuka Y., et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 27(1):15-20.